Wednesday, 26 August 2026European Markets

LATECOERE Stock Bearish By 33% So Far On Wednesday

Loading stream...

(vianews) - shares of latecoere (cac 40: lat.pa) fell by a staggering 33.77% to €0.20 at 14:58 est on wednesday, after four sequential sessions in a row of losses. cac 40 is jumping 1.26% to €7,177.49, after two consecutive sessions in a row of gains. this seems, at the moment, an all-around positive trend trading session today.

about latecoere

latécoère s.a. designs, develops, manufactures, and supports aerostructures and interconnection systems in europe, the united states, africa, asia, and internationally. the company manufactures aircraft structural elements, such as aircraft doors; and fuselage components, such as aircraft sections, tail cones, nose cone fairings, etc. it also offers electrical harnesses and wiring interconnection systems, avionics racks, airborne video equipment and systems, and test benches for the aeronautics, defense, and space sectors, as well as cameras, screens, data transmission solutions. the company was founded in 1917 and is headquartered in toulouse, france. latécoère s.a. is a subsidiary of scp skn holding i sas.

earnings per share

as for profitability, latecoere has a trailing twelve months eps of €-2.

volatility

latecoere's last week, last month's, and last quarter's current intraday variation average was a negative 5.43%, a negative 1.36%, and a positive 3.08%.

latecoere's highest amplitude of average volatility was 5.43% (last week), 4.00% (last month), and 3.08% (last quarter).

more news about latecoere (lat.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com